Part I — Before the Mystery
What came before DMT, how the molecule entered chemistry, the move from chemical identity to psychological question, and a molecule found in nature.

Published · Ebook edition available · The Spore Patch Ltd
Volume III · DMT
The third volume of Richard L. Pope's nine-volume audit turns to N,N-dimethyltryptamine. Few molecules carry as much interpretation per minute of effect, and few have had as much built on top of so little measurement. Forty chapters across eight parts separate what has been demonstrated from what has travelled by repetition: the endogenous question, the short intense human studies, the brain work, the clinical return, and the claim machine that grew around all of it.
Published as a reflowable EPUB 3 ebook, £7.99. The download link is sent by email after checkout.
Two ways to read. Every purchase includes both the EPUB download and online reading: sign in with the email you bought with and Volume III opens in your browser from your own library, which remembers where you left off.
The governing principle
One name can cover several evidential objects. An injected laboratory dose, an inhaled dose, an extended infusion and a molecule detected in tissue are not interchangeable, and a receptor does not automatically become an experience. Where a claim moves between containers, the move is stated rather than assumed.
Volume III structure
Eight parts, forty chapters, with a preface, an introduction on the several evidential objects behind one name, and a closing account of the claims that survived.
What came before DMT, how the molecule entered chemistry, the move from chemical identity to psychological question, and a molecule found in nature.
What has actually been detected, the measurement problem, biosynthesis and metabolism, the pineal gland claim, and the evidence gap around dreams, birth and death.
When DMT entered human investigation, the early experimental record, what those first studies could and could not show, the return of controlled research, and the ethics of the experimental setting.
There is no single DMT experience: perception, time and the uncertain self, apparent entities, the problem of reporting, noetic force, and the stories readers bring with them.
The receptor is still not the experience: electrical activity, imaging and network reorganisation, predictive processing, and when a neural correlate becomes a story.
Why DMT returned to psychiatry, the first controlled signals in depression, the therapeutic package around the molecule, blinding, follow-up, and what small trials cannot count.
The endogenous-DMT myth machine, near-death claims, whether there is evidence for a “DMT realm”, when experience becomes ontology, and commercial certainty before clinical evidence.
The experiments worth doing, and the claims that survived the audit.
Apparatus
The volume closes with an Atlas glossary and concept index, followed by a single consolidated reference list covering every chapter, so that each claim can be traced back to the literature it rests on.
Shared series vocabulary — evidential object, container, claim transfer, noetic force — defined in one place, so the same words carry the same weight across volumes.
A single reference list at the end of the volume rather than scattered notes. Where the evidence runs out, the volume says so rather than filling the gap with a citation that does not support the claim.
The author
Author of The Fungal Evidence Atlas and The Psychedelic Evidence Atlas, published by The Spore Patch Ltd. No academic affiliations, qualifications, awards or endorsements are claimed, and none should be inferred.
The Psychedelic Evidence Atlas, Volume III: DMT. First edition, 2026. Published by The Spore Patch Ltd as a reflowable EPUB 3 ebook. Text copyright Richard L. Pope.
Availability
This edition is a digital publication only. The Spore Patch Ltd sells digital publications and does not sell mushrooms, supplements or remedies.
This volume is an evidence audit. It is not medical, psychological or legal advice, and nothing in it encourages the obtaining, possession or use of any controlled substance.